『PMHNP Certification Q & A』のカバーアート

PMHNP Certification Q & A

PMHNP Certification Q & A

著者: Fitzgerald Health Education Associates
無料で聴く

This podcast is for NP students studying to pass their PMHNP certification exam. Expert Fitzgerald faculty clinicians share their knowledge and experience to help you dissect the anatomy of a test question so you can better understand how to arrive at the correct test answer.

© 2026 PMHNP Certification Q & A
教育
エピソード
  • Managing Treatment-Resistant Schizophrenia
    2026/07/22

    The PMHNP is managing a patient with treatment-resistant schizophrenia who continues to have positive symptoms despite appropriate trials with two different antipsychotic regimens. When considering initiation of clozapine, the NP considers that which of the following apply?

    A. The absolute neutrophil count must be > 1000/mm3 to start treatment

    B. The first 2-3 doses should be administered in a closely monitored setting with vital signs monitored regularly

    C. The medication must be ministered in accordance with the FDA REMS safety monitoring

    D. The medication has significantly less medication interaction potential as compared to other antipsychotics

    ---

    YouTube: https://www.youtube.com/watch?v=GH7CZF80ghI&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=130





    続きを読む 一部表示
    9 分
  • Laboratory Abnormalities in a Patient With Anorexia Nervosa
    2026/07/15

    The PMHNP has just accepted a position at an eating disorders clinic which offers a multi-disciplinary approach to the management of eating disorders, including psychiatric comorbidities and physical health deviations. In preparing for the role, the NP reviews strategies for managing which of the following laboratory abnormalities common in patients with anorexia nervosa?

    A. Hypercholesterolemia, leukopenia, low TSH

    B. Anemia, hyperkalemia, low T3.

    C. Hypokalemia, hypocholesterolemia, hypernatremia.

    D. Anemia, low eGFR, hypernatremia.

    ---

    YouTube: https://www.youtube.com/watch?v=Ix9Xaq7uTIM&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=129

    続きを読む 一部表示
    8 分
  • Adolescent Insomnia in a Patient With Generalized Anxiety Disorder
    2026/07/08

    A 14-year-old patient is being managed for generalized anxiety disorder and has been responding well to fluoxetine. However, both the patient and his mother report that he has chronic difficulty falling asleep. He denies any racing thoughts at bedtime; he just cannot seem to fall asleep. His mother has been giving him melatonin gummies purchased over the counter from the pharmacy and reports that there is some improvement but would like to know what else can be done.

    The PMHNP advises which of the following interventions that are recommended for adolescent insomnia? Choose all that apply.

    A. The melatonin gummies should be discontinued

    B. The adolescent should not be permitted screen time at least one hour before bed.

    C. Establish a later bedtime

    D. Eliminate daytime napping.

    ---

    YouTube: https://www.youtube.com/watch?v=ZHl59bdwpJM&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=128


    続きを読む 一部表示
    9 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません